Cargando…
Prognostic value of pretreatment serum levels of lactate dehydrogenase in nonmetastatic nasopharyngeal carcinoma: single-site analysis of 601 patients in a highly endemic area
BACKGROUND: Numerous studies have generated promising but incomplete evidence for the prognostic value of pretreatment serum levels of lactate dehydrogenase (S-LDH) in nasopharyngeal carcinoma (NPC). METHODS: Pretreatment serum levels of S-LDH in 601 patients with NPC were measured before treatment,...
Autores principales: | Wei, Zhengbo, Zeng, Xianjie, Xu, Jian, Duan, Xuwei, Xie, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031205/ https://www.ncbi.nlm.nih.gov/pubmed/24868167 http://dx.doi.org/10.2147/OTT.S59804 |
Ejemplares similares
-
Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era
por: Chen, Zhuhong, et al.
Publicado: (2017) -
Prognostic significance of pretreated serum lactate dehydrogenase level in nasopharyngeal carcinoma among Chinese population: A meta-analysis
por: Zhang, Mingwei, et al.
Publicado: (2016) -
Pretreatment Serum Lactate Dehydrogenase and Metastases Numbers as Potential Determinants of Anti-PD-1 Therapy Outcome in Nasopharyngeal Carcinoma
por: Ali, Wael A. S., et al.
Publicado: (2023) -
Pretreatment Aspartate Aminotransferase-to-Alanine Aminotransferase (De Ritis) Ratio Predicts the Prognosis of Nonmetastatic Nasopharyngeal Carcinoma
por: Wu, Jiayuan, et al.
Publicado: (2019) -
Current Role of Chemotherapy in Nonmetastatic Nasopharyngeal Cancer
por: Bhattacharyya, Tapesh, et al.
Publicado: (2018)